BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29496540)

  • 1. Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza.
    Littauer EQ; Mills LK; Brock N; Esser ES; Romanyuk A; Pulit-Penaloza JA; Vassilieva EV; Beaver JT; Antao O; Krammer F; Compans RW; Prausnitz MR; Skountzou I
    J Control Release; 2018 Apr; 276():1-16. PubMed ID: 29496540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines.
    Zhu W; Pewin W; Wang C; Luo Y; Gonzalez GX; Mohan T; Prausnitz MR; Wang BZ
    J Control Release; 2017 Sep; 261():1-9. PubMed ID: 28642154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination.
    Chen YH; Lai KY; Chiu YH; Wu YW; Shiau AL; Chen MC
    Acta Biomater; 2019 Oct; 97():230-238. PubMed ID: 31362139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
    Vassilieva EV; Kalluri H; McAllister D; Taherbhai MT; Esser ES; Pewin WP; Pulit-Penaloza JA; Prausnitz MR; Compans RW; Skountzou I
    Drug Deliv Transl Res; 2015 Aug; 5(4):360-71. PubMed ID: 25895053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity.
    Wang BZ; Gill HS; He C; Ou C; Wang L; Wang YC; Feng H; Zhang H; Prausnitz MR; Compans RW
    J Control Release; 2014 Mar; 178():1-7. PubMed ID: 24417966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Immune Responses Conferring Cross-Protection by Skin Vaccination With a Tri-Component Influenza Vaccine Using a Microneedle Patch.
    Zhu W; Li S; Wang C; Yu G; Prausnitz MR; Wang BZ
    Front Immunol; 2018; 9():1705. PubMed ID: 30105019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
    Kim MC; Lee JW; Choi HJ; Lee YN; Hwang HS; Lee J; Kim C; Lee JS; Montemagno C; Prausnitz MR; Kang SM
    J Control Release; 2015 Jul; 210():208-16. PubMed ID: 26003039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection.
    Kim YC; Lee SH; Choi WH; Choi HJ; Goo TW; Lee JH; Quan FS
    J Drug Target; 2016 Dec; 24(10):943-951. PubMed ID: 26957023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-di-GMP with influenza vaccine showed enhanced and shifted immune responses in microneedle vaccination in the skin.
    Shin JH; Lee JH; Jeong SD; Noh JY; Lee HW; Song CS; Kim YC
    Drug Deliv Transl Res; 2020 Jun; 10(3):815-825. PubMed ID: 32141036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza virus-like particles composed of conserved influenza proteins and GPI-anchored CCL28/GM-CSF fusion proteins enhance protective immunity against homologous and heterologous viruses.
    Liu J; Ren Z; Wang H; Zhao Y; Wilker PR; Yu Z; Sun W; Wang T; Feng N; Li Y; Wang H; Ji X; Li N; Yang S; He H; Qin C; Gao Y; Xia X
    Int Immunopharmacol; 2018 Oct; 63():119-128. PubMed ID: 30081250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
    Quan FS; Kim YC; Song JM; Hwang HS; Compans RW; Prausnitz MR; Kang SM
    Clin Vaccine Immunol; 2013 Sep; 20(9):1433-9. PubMed ID: 23863506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin vaccination with dissolvable microneedle patches incorporating influenza neuraminidase and flagellin protein nanoparticles induces broad immune protection against multiple influenza viruses.
    Wang Y; Li S; Dong C; Ma Y; Song Y; Zhu W; Kim J; Deng L; Denning TL; Kang SM; Prausnitz MR; Wang BZ
    ACS Appl Bio Mater; 2021 Jun; 4(6):4953-4961. PubMed ID: 34179728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring.
    Esser ES; Pulit-Penaloza JA; Kalluri H; McAllister D; Vassilieva EV; Littauer EQ; Lelutiu N; Prausnitz MR; Compans RW; Skountzou I
    Sci Rep; 2017 Jul; 7(1):5705. PubMed ID: 28720851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertion-responsive microneedles for rapid intradermal delivery of canine influenza vaccine.
    Choi IJ; Kang A; Ahn MH; Jun H; Baek SK; Park JH; Na W; Choi SO
    J Control Release; 2018 Sep; 286():460-466. PubMed ID: 30102940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolving polymer microneedle patches for influenza vaccination.
    Sullivan SP; Koutsonanos DG; Del Pilar Martin M; Lee JW; Zarnitsyn V; Choi SO; Murthy N; Compans RW; Skountzou I; Prausnitz MR
    Nat Med; 2010 Aug; 16(8):915-20. PubMed ID: 20639891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved influenza vaccination in the skin using vaccine coated microneedles.
    Kim YC; Quan FS; Yoo DG; Compans RW; Kang SM; Prausnitz MR
    Vaccine; 2009 Nov; 27(49):6932-8. PubMed ID: 19761836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal influenza immunization with vaccine-coated microneedle arrays.
    Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Sullivan SP; Compans RW; Prausnitz MR; Skountzou I
    PLoS One; 2009; 4(3):e4773. PubMed ID: 19274084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.
    Kim YC; Quan FS; Yoo DG; Compans RW; Kang SM; Prausnitz MR
    J Infect Dis; 2010 Jan; 201(2):190-8. PubMed ID: 20017632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.
    Quan FS; Kim YC; Compans RW; Prausnitz MR; Kang SM
    J Control Release; 2010 Nov; 147(3):326-32. PubMed ID: 20692307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of zymosan and poly (I:C) adjuvants on responses to microneedle immunization coated with whole inactivated influenza vaccine.
    Shin JH; Noh JY; Kim KH; Park JK; Lee JH; Jeong SD; Jung DY; Song CS; Kim YC
    J Control Release; 2017 Nov; 265():83-92. PubMed ID: 28890214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.